hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06290804, orgStudyIdInfo id: drezgiyucel0000000193593877, briefTitle: Assessing Sustainable Behaviors and Health Impacts of Climate Change, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-01-15, primaryCompletionDateStruct date: 2024-03, completionDateStruct date: 2024-07, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Eskisehir Osmangazi University, class: OTHER, descriptionModule briefSummary: The relationship between climate change, sustainability and child health is complex and important. These three concepts are interacting factors and have significant impacts on children's health. Sustainability measures are vital to protect child health by mitigating the impacts of climate change. At the same time, children's education and awareness is an important factor that will contribute to future generations living in a sustainable world. As a society, tackling climate change and striving for a sustainable future is crucial to ensure that children live healthy and safe lives. The aim of this study is to evaluate the effectiveness of the education program and educational videos to be applied to children in terms of environmentally sustainable behaviors and awareness of the health effects of climate change in 60-72-month-old children studying in Eskişehir Odunpazarı Municipality Day Care Center and Nurseries. In addition, in this study, it was aimed to measure the level of global climate change awareness of parents and to evaluate the relationship with children's environmentally sustainable behaviors., conditionsModule conditions: Climate Change, conditions: Child Health, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: SEQUENTIAL, primaryPurpose: PREVENTION, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 38, type: ESTIMATED, armsInterventionsModule interventions name: education, outcomesModule primaryOutcomes measure: increasing sustainable behaviors, primaryOutcomes measure: raising awareness of the health impacts of climate change, primaryOutcomes measure: raising awareness of global climate change, eligibilityModule sex: ALL, minimumAge: 60 Months, maximumAge: 72 Months, stdAges: CHILD, contactsLocationsModule locations facility: Ezgi Yücel, city: Odunpazarı, state: Eskişehir, zip: 553 723 43 57, country: Turkey, geoPoint lat: 39.76821, lon: 30.53538, hasResults: False
protocolSection identificationModule nctId: NCT06290791, orgStudyIdInfo id: K2020214, briefTitle: Does a Drain Tube Influence the Postoperative Epidural Haematoma for Lumbar Biportal Endoscopic Surgery?, statusModule overallStatus: COMPLETED, startDateStruct date: 2020-12-31, primaryCompletionDateStruct date: 2023-12-31, completionDateStruct date: 2024-02-10, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: The Fourth Affiliated Hospital of Zhejiang University School of Medicine, class: OTHER, descriptionModule briefSummary: The purpose of this study was to evaluate if wound drains could influence postoperative spinal epidural hematoma (POSEH) in biportal endoscopic spinal surgery (BESS) procedures for decompression of lumbar spinal stenosis., conditionsModule conditions: Drain Tube Influence the Postoperative Epidural Haematoma, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 89, type: ACTUAL, armsInterventionsModule interventions name: two level lumbar decompression with BESS procedure received one drain., interventions name: two level lumbar decompression with BESS procedure received two drain., outcomesModule primaryOutcomes measure: the cross-sectional area of POSEH, secondaryOutcomes measure: the volume of drain output, eligibilityModule sex: ALL, minimumAge: 20 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Zhonglin Zhong, city: Yiwu, state: Zhejiang, zip: 322000, country: China, geoPoint lat: 29.31506, lon: 120.07676, hasResults: False
protocolSection identificationModule nctId: NCT06290778, orgStudyIdInfo id: Baylor IRB #023-445, briefTitle: Peer Delivered, Emotion Regulation-Focused Mental Health Prevention Training for Fire Fighter Trainees, acronym: PEER UP, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2027-08, completionDateStruct date: 2027-08, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Baylor Research Institute, class: OTHER, collaborators name: University of Pittsburgh, collaborators name: Boston University, collaborators name: Texas A&M University, descriptionModule briefSummary: The goal of this clinical trial is to determine if a peer-delivered emotion regulation training (Brief-Unified Protocol) workshop is effective for preventing posttraumatic stress and other psychological health symptoms in firefighter trainees. The main questions it aims to answer are:* Do firefighter recruits who receive peer-delivered Brief-Unified Protocol report lower PTSD symptom severity over time compared to those who receive psychoeducation?* Do firefighter recruits who receive peer-delivered Brief-Unified Protocol report lower AUD, depression, anxiety, and functional impairment symptom severity over time compared to those who receive psychoeducation?* Do changes in neuroticism or emotion regulation mediate the effect of receiving the Brief-Unified Protocol on the treatment outcomes?Participants will:* Participate in a Brief-Unified Protocol workshop or psychoeducation workshop during fire academy training.* Complete a questionnaire and clinical interview prior to the workshop.* Complete a questionnaire immediately following the workshop and follow up questionnaires at 6, 12, 18, and 24 months after completing the fire academy.Researchers will compare firefighters who receive a peer-delivered Brief-Unified Protocol workshop to firefighters who receive peer-delivered psychoeducation to see if the Brief-Unified Protocol is effective for preventing posttraumatic stress and other psychological health symptoms., conditionsModule conditions: PTSD, conditions: Alcohol Use Disorder, conditions: Depression, conditions: Anxiety, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 480, type: ESTIMATED, armsInterventionsModule interventions name: Brief Unified Protocol, interventions name: Psychoeducation, outcomesModule primaryOutcomes measure: PTSD Symptoms, secondaryOutcomes measure: Alcohol Use Disorder symptoms, secondaryOutcomes measure: Depression symptoms, secondaryOutcomes measure: Anxiety symptoms, secondaryOutcomes measure: Functional Impairment, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06290765, orgStudyIdInfo id: A23-401, briefTitle: Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Low-Risk Polycythemia Vera, acronym: PV, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07-01, primaryCompletionDateStruct date: 2025-12-31, completionDateStruct date: 2027-02-28, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: PharmaEssentia, class: INDUSTRY, descriptionModule briefSummary: This is a randomized, open-label, multicenter, two-arm study to assess the efficacy and safety of ropeginterferon alfa-2b for patients with low-risk PV. Approximately 110 patients with low-risk PV will be enrolled. The whole study period is 108 weeks, including a main treatment phase (56 weeks), an extension treatment phase (48 weeks), and a safety follow-up phase (four weeks)., conditionsModule conditions: Polycythemia Vera, conditions: Myeloproliferative Neoplasm, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 110, type: ESTIMATED, armsInterventionsModule interventions name: Ropeginterferon alfa-2b, interventions name: Phlebotomy, outcomesModule primaryOutcomes measure: The proportion of patients with treatment response evaluated. Treatment response is defined as the maintenance of the median HCT values <45% over time, without progression of disease, and no need of any extra-protocol cytoreductive drugs., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 59 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06290752, orgStudyIdInfo id: KY-2024-030, briefTitle: Determining the Learning Curve for Ultrasound-guided Caudal Epidural Block, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-11-30, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: The Fourth Affiliated Hospital of Zhejiang University School of Medicine, class: OTHER, descriptionModule briefSummary: mastering ultrasound-guided sacral canal block entails traversing a multifaceted learning curve characterized by anatomical intricacies, technical challenges, and patient variability. Through systematic education, deliberate practice, and clinical experience, clinicians can ascend this learning curve and harness the full potential of this innovative technique in pain management. As the landscape of regional anesthesia continues to evolve, a commitment to ongoing learning and proficiency attainment is paramount for delivering safe, effective, and patient-centered care., conditionsModule conditions: Anesthesia, designModule studyType: OBSERVATIONAL, designInfo observationalModel: ECOLOGIC_OR_COMMUNITY, timePerspective: PROSPECTIVE, enrollmentInfo count: 6, type: ESTIMATED, outcomesModule primaryOutcomes measure: operation time, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Dongmei Ma, status: RECRUITING, city: Yiwu, state: Zhejiang, zip: 322000, country: China, contacts name: Zhu Xinqiang, role: CONTACT, phone: +8657989935052, geoPoint lat: 29.31506, lon: 120.07676, hasResults: False
protocolSection identificationModule nctId: NCT06290739, orgStudyIdInfo id: JHuang886, briefTitle: A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-07, primaryCompletionDateStruct date: 2024-03-07, completionDateStruct date: 2024-03-27, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: West China Hospital, class: OTHER, descriptionModule briefSummary: The object of this study is to develop a model for prediction of lymph node metastasis among intrahepatic cholangiocarcinoma (ICC) patients. Intrahepatic cholangiocarcinoma is the second most common kind of primary liver cancer, accounting for approximately 10%-15%. There is a lack of agreement regarding the necessity of performing lymph node dissection (LND) in patients with ICC. Currently, the percentage of LND is below 50%, and the rate of sufficient LND (≥6) has plummeted to less than 20%. Consequently, a large proportion of patients are unable to acquire LN status, which hinders the following systematic treatment strategies after surgery:. Therefore, our objective is to construct a LN metastasis model utilizing machine learning techniques, including patients' clinical data and pathology information, with the goal of offering a reference for patients who have not undergone LND or have had inadequate LND., conditionsModule conditions: Intrahepatic Cholangiocarcinoma, conditions: Machine Learning, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 300, type: ESTIMATED, armsInterventionsModule interventions name: lymph nodes dissection, outcomesModule primaryOutcomes measure: Overall survival, secondaryOutcomes measure: Disease free survival, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, status: RECRUITING, city: Chengdu, state: Sichuan, zip: 610041, country: China, contacts name: fengmin Luo, Doctor, role: CONTACT, phone: +86 028-85582944, email: hxyyhfb@163.com, geoPoint lat: 30.66667, lon: 104.06667, hasResults: False
protocolSection identificationModule nctId: NCT06290726, orgStudyIdInfo id: 202001927B0, briefTitle: Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients, statusModule overallStatus: COMPLETED, startDateStruct date: 2002-02, primaryCompletionDateStruct date: 2016-02, completionDateStruct date: 2024-01, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Chang Gung Memorial Hospital, class: OTHER, descriptionModule briefSummary: The goal of this observational study is to compare in anti-HBc (+) grafts/ anti-HBc (-) grafts. The main question it aims to answer is the long-term efficacy of active vaccination and graft/patient outcomes of anti-HBc (+) grafts have yet to be comprehensively investigated. Researchers will compare anti-HBc (+) grafts/ anti-HBc (-) to see if it would affect the long-term survival., conditionsModule conditions: Living Donor Liver Transplantations With Anti-HBc (+) Grafts, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 204, type: ACTUAL, armsInterventionsModule, outcomesModule primaryOutcomes measure: Long-term survival in pediatric recipients of living donor liver transplantations with anti-HBc (+) grafts, eligibilityModule sex: ALL, minimumAge: 4 Months, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06290700, orgStudyIdInfo id: MCBU_2880, briefTitle: Effect of Neonatal Care Education for Primiparous Pregnant Women on Postpartum Maternal Function and Quality of Life, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-11-01, primaryCompletionDateStruct date: 2024-02-01, completionDateStruct date: 2024-02-01, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Celal Bayar University, class: OTHER, descriptionModule briefSummary: This study aimed to evaluate the effect of neonatal care education for primiparous pregnant women on postpartum maternal function and quality of life., conditionsModule conditions: Life Quality, conditions: Functional Status, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 126, type: ACTUAL, armsInterventionsModule interventions name: Neonatal Care education, outcomesModule primaryOutcomes measure: severity of maternal function by Barkin Index of Maternal Functioning, secondaryOutcomes measure: Maternal Postpartum Quality of Life Instrument, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 45 Years, stdAges: ADULT, contactsLocationsModule locations facility: Yonca ÇIÇEK OKUYAN, city: Manisa, country: Turkey, geoPoint lat: 38.61202, lon: 27.42647, hasResults: False
protocolSection identificationModule nctId: NCT06290687, orgStudyIdInfo id: CASE5824, briefTitle: Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-08, primaryCompletionDateStruct date: 2026-01-29, completionDateStruct date: 2027-01-29, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Case Comprehensive Cancer Center, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to determine if a partial cystectomy with extended pelvic lymph node removal will be effective at treating Muscle-Invasive Bladder Cancer instead of a complete cystectomy with extended pelvic lymph node removal. This clinical trial aims to determine the safety and oncologic efficacy of the intervention, and to examine patient-reported quality of life outcomes in participants. Participants will receive the standard pre-surgery treatment for approximately 4 to 6 weeks. After the pre-surgery treatment is completed, participants will undergo a partial cystectomy with extended pelvic lymph node dissection. After surgery, participants will receive adjuvant systemic therapy., conditionsModule conditions: Malignant Neoplasm of Bladder, conditions: Muscle Invasive Bladder Carcinoma, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: This is a single-center, prospective, phase II trial., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Neoadjuvant Chemotherapy, interventions name: Partial cystectomy with Extended pelvic lymph node dissection, interventions name: Adjuvant systemic therapy, outcomesModule primaryOutcomes measure: Recurrence-Free Survival (RFS), secondaryOutcomes measure: Presence of Post-operative Complications, secondaryOutcomes measure: Median Bladder RFS, secondaryOutcomes measure: Median Muscle-Invasive Bladder RFS, secondaryOutcomes measure: Median Bladder-Intact Survival, secondaryOutcomes measure: Median Cancer-Specific Survival, secondaryOutcomes measure: Changes in Genitourinary-specific HRQoL, eligibilityModule sex: ALL, minimumAge: 19 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Glickman Urological and Kidney Institute, Cleveland Clinic, Case Comprehensive Cancer Center, city: Cleveland, state: Ohio, zip: 44195, country: United States, contacts name: Nima Almassi, MD, role: CONTACT, phone: 216-444-1825, email: almassn2@ccf.org, geoPoint lat: 41.4995, lon: -81.69541, hasResults: False
protocolSection identificationModule nctId: NCT06290674, orgStudyIdInfo id: P.T.REC/012/004043, briefTitle: Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-09-11, primaryCompletionDateStruct date: 2024-01-01, completionDateStruct date: 2024-02-01, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Adly A Adam, class: OTHER, descriptionModule briefSummary: Almost postmenopausal women store significant extra visceral adipose tissue with unexplained mechanism, yet. Postmenopausal obese women with excess abdominal obesity have raised metabolic risk of numerous cardiovascular diseases, which negatively influence health policy concern. Therefore, actual need to recommend non-invasive approach that cover this lack of quantitative knowledge in clinical management of obese postmenopausal women., conditionsModule conditions: Obesity, Abdominal, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Clinical randomized controlled study, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, maskingDescription: Double masking (Investigator and Participant), whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: Extracorporeal Shockwave therapy, interventions name: Balanced low-calorie diet, outcomesModule primaryOutcomes measure: Waist/ hip ratio, primaryOutcomes measure: Skin fold caliper, secondaryOutcomes measure: Lipid profile, eligibilityModule sex: FEMALE, minimumAge: 45 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Helwan General Hospital, city: Cairo, state: Helwan, Cairo Governate, zip: 02, country: Egypt, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06290648, orgStudyIdInfo id: 22-0868, secondaryIdInfos id: 5R34MH130555, type: NIH, link: https://reporter.nih.gov/quickSearch/5R34MH130555, briefTitle: Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings, acronym: FNP, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2025-12, completionDateStruct date: 2025-12, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: University of North Carolina, Chapel Hill, class: OTHER, collaborators name: National Institute of Mental Health (NIMH), descriptionModule briefSummary: The goal of this clinical trial is to conduct a preliminary test of the effectiveness of Forging New Paths for people with mental illness with criminal legal system contact. The main question\[s\] it aims to answer are:1. To examine the effectiveness of Forging New Paths at improving the primary study outcomes (aggression and community tenure).2. To test the ability of Forging New Paths to engage the study treatment targets (impulsivity and criminal attitudes)Participants will complete a screening interviews to see if they are eligible. Participants who are eligible will be randomly assigned to participate in one of two study conditions: Forging New Paths and usual care or usual care alone. All participants who are assigned to a study condition will participate in up to three additional research interviews. Researchers will also collect information about study outcomes using administrative records., conditionsModule conditions: Mental Illness, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 72, type: ESTIMATED, armsInterventionsModule interventions name: Forging New Paths, outcomesModule primaryOutcomes measure: Change in Levels of Aggression Score from Baseline to Month 3, primaryOutcomes measure: Change in Levels of Aggression Score From Baseline to Month 6, primaryOutcomes measure: Community Tenure, secondaryOutcomes measure: Change in Overall Criminal Attitudes Score, secondaryOutcomes measure: Change in Overall Impulsivity Score, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of North Carolina at Chapel Hill, city: Chapel Hill, state: North Carolina, zip: 27599, country: United States, contacts name: Amy Wilson, PhD, role: CONTACT, geoPoint lat: 35.9132, lon: -79.05584, hasResults: False